MASLD
Metabolic dysfunction-associated steatotic liver disease. Formerly NAFLD. An active research indication for GLP-1 agonists and tesamorelin.
Metabolic dysfunction-associated steatotic liver disease. Formerly NAFLD. An active research indication for GLP-1 agonists and tesamorelin.